G & W Laboratories Inc.

Quick facts

Phase 3 pipeline

• Reference: Tazorac Cream, 0.05% · Dermatology
  Tazorac Cream, 0.05% is a topical retinoid that works by promoting cell turnover and preventing the formation of comedones, thereby reducing acne severity.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• G & W Laboratories Inc. portfolio CI brief
• G & W Laboratories Inc. pipeline updates RSS